Epidemiology and Trend of Incidence of the Leukemia in Iran

Document Type : Original Article (s)

Authors

1 MSc Student, Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

2 MSc Student, Department of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran

3 Epidemiologist, Minimally Invasive Surgery Research Center, Iran University of Medical Sciences AND Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Leukemia makes up about 8% of all cancers. Understanding the epidemiology of leukemia is very effective in planning for this cancer. According to lack of information in the field, the present study aimed to investigate the epidemiology and trend of incidence of leukemia in Iran during 2003 to 2010.Methods: This cross-sectional study was conducted using the analysis data from the Iranian National Cancer Registration System and Disease Management Center, Ministry of Health and Medical Education during the years 2003 to 2010. The incidence rates were calculated by age and gender and the trend of incidence of the disease by sex during this period was achieved.Findings: Evaluation of cancer registration data in the years 2003 to 2010 showed the ascending trend of leukemia in Iran. 21814 cases of leukemia were recorded in the whole country that increased from 1734 cases in 2003 to 3461 cases in 2010. The highest and the lowest incidence in women and men were reported in years 2009 and 2003, respectively. In the provinces of country, the highest reported incidence in women was in Yazd and the lowest incidence was in Semnan, Kermanshah, Qom and Kohgiluyeh and Boyer Ahmad; and for men, the highest incidence was in Yazd and the lowest incidence was in Zanjan, North and South Khorasan, Semnan, Ardebil and Kohgiluyeh and Boyer Ahmad. The sex ratio of male to female was 1.64.Conclusion: Based on the results, the incidence of leukemia in Iran is rising. Although a proportion of this increase may be due to improvements in cancer registration system but the probability of increase of incidence of leukemia exists because of the associated risk factors. Thus, the identification of the risk factors in different regions of Iran to prevent and to detect the disease at an early stage in recommended for disease control.

Keywords

References

  1. Hemmati K, Mohagheghi MA, Mousavi-Jarahi A, Khabbaz-Khoob M. Cancer incidence in Ilam. J Ilam Univ Med Sci 2009; 17(3): 24-32. [In Persian].
  2. Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: Southeast of Iran. Asian Pac J Cancer Prev 2015; 16(4): 1409-13.
  3. Almasi Z, Rafiemanesh H, Salehiniya H. Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev 2015; 16(7): 2757-61.
  4. Aghajani H, Eatemad K, Goya M, Ramezani R, Modirian M. National cancer registry report 2008/2009. Tehran, Iran: Center for Disease Control; 2011.
  5. International Agency for reserch Cancer. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 [Online]. [cited 2012]; Available from: http://globocan.iarc.fr/Default.aspx.
  6. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, editors. SEER cancer statistics review, 1975-2011. Bethesda, MD: National Cancer Institute; 2013.
  7. Zand AM, Imani S, Sa'adati M, Borna H, Ziaei R, Honari H. Effect of age, gender and blood group on blood cancer types. Kowsar Med J 2010; 15(2): 111-4. [In Persian].
  8. Mahmoudi M , Tahmasebi B , Yahya Pour Y , Jamshidi M , Halakooei Naeini K. Determination and comparison of incidence rate and trend of morbidity of leukemia and lymphoma in Mazandaran province, 1376-82. J Mazandaran Univ Med Sci 2006; 16(54): 82-9. [In Persian].
  9. Almasi-Hashiani AA, Zareifar S, Hosseini SH, Dehghan A. Determination of the risk factors involved in recurrence of leukemia in children, Fars Province, Iran (2004-09). J Arak Univ Med Sci 2012; 15(2): 1-7. [In Persian].
  10. van den Broek EC, Kater AP, van de Schans SA, Karim-Kos HE, Janssen-Heijnen ML, Peters WG, et al. Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008. Eur J Cancer 2012; 48(6): 889-95.
  11. Thygesen LC, Nielsen OJ, Johansen C. Trends in adult leukemia incidence and survival in Denmark, 1943-2003. Cancer Causes Control 2009; 20(9): 1671-80.
  12. Coebergh JW, Reedijk AM, de VE, Martos C, Jakab Z, Steliarova-Foucher E, et al. Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42(13): 2019-36.
  13. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood 2012; 119(1): 34-43.
  14. Levi F, Lucchini F, Negri E, Barbui T, La VC. Trends in mortality from leukemia in subsequent age groups. Leukemia 2000; 14(11): 1980-5.
  15. Maynadie M, Girodon F, Manivet-Janoray I, Mounier M, Mugneret F, Bailly F, et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France). Haematologica 2011; 96(1): 55-61.
  16. Novak I, Jaksic O, Kulis T, Batinjan K, Znaor A. Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009. Croat Med J 2012; 53(2): 115-23.
  17. Sant M, Allemani C, Tereanu C, De AR, Capocaccia R, Visser O, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010; 116(19): 3724-34.
  18. Rahimi F، Heidari M. Time trend analysis of stomach cancer incidence in the west of Iran. J Health Dev 2012; 1(2): 100-11. [In Persian].
  19. Goya M. Iranian Annual Cancer Registration Report 2005/2006. Tehran, Iran: Ministry of Health and Medical Education، Health Deputy. Center for Disease Control and Prevention 2007. [In Persian].
  20. Farahmand M, Almasi-Hashiani A, Mohammad Beigi A, Raei-Dehaghi M, Ajdari A. The epidemiology of childhood hematopoietic and reticuloendothelial cancer based on Fars province cancer registry data system from 2001 to 2008. Daneshvar Med 2011; 18(94): 27-34. [In Persian].
  21. Hejazi S، Gholami A، Salarilak S، Khalkhali HR، Moosavi Jahromi L. Incidence rate of acute leukemia in West Azarbaijan during 2003-2008. Urmia Med J 2010; 21(2): 243-8. [In Persian].
  22. Koohi F, Salehiniya H, Shamlou R, Eslami S, Mahery Ghojogh Z, Kor Y, et al. Leukemia in Iran: Epidemiology and morphology trends. Asian Pac J Cancer Prev 2016; 16(17): 7759-63.
  23. Zahedi A, Rafiemanesh H, Enayatrad M, Ghoncheh M, Salehiniya H. Incidence, trends and epidemiology of cancers in north west of Iran. Asian Pac J Cancer Prev 2015; 16(6): 7189-93.
  24. Razi S, Rafiemanesh H, Ghoncheh M, Khani Y, Salehiniya H. Changing trends of types of skin cancer in Iran. Asian Pac J Cancer Prev 2015; 16(12): 4955-8.
Journal of Isfahan Medical School
Volume 33, Issue 361 - Serial Number 361
November and December 2016
Pages 2055-2061

Files

History

  • Receive Date: 18 July 2015
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics